Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Levamlodipine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1C known ✓ | Q13936 | 1/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 3/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 3/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 3/20 | 1.00 |
| ▸ | HTR1A | P08908 | 2/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 2/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 2/20 | 1.00 |
| ▸ | DRD1 | P21728 | 2/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 2/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 2/20 | 1.00 |
| ▸ | DRD3 | P35462 | 2/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 2/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 2/20 | 1.00 |
| ▸ | ADRB3 | P13945 | 2/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 2/20 | 1.00 |
| ▸ | SCN5A | Q14524 | 2/20 | 1.00 |
| ▸ | KCNK2 | O95069 | 1/20 | 1.00 |
| ▸ | ADRB2 | P07550 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amlodipine SCHEMBL912531 | 1.00 | TBXA2R (1.00) | TBXA2RADRA1ASLC6A3ADORA3ABCB11 | |
| Levamlodipine SCHEMBL30994756 | 1.00 | TBXA2R (1.00) | TBXA2RADRA1ASLC6A3ADORA3ABCB11 | |
| Amlodipine SCHEMBL7174865 | 1.00 | TBXA2R (1.00) | TBXA2RADRA1ASLC6A3ADORA3ABCB11 | |
| Amlodipine SCHEMBL29397019 | 1.00 | TBXA2R (1.00) | TBXA2RADRA1ASLC6A3ADORA3ABCB11 | |
| Amlodipine SCHEMBL1816641 | 1.00 | TBXA2R (1.00) | TBXA2RADRA1ASLC6A3ADORA3ABCB11 | |
| Amlodipine SCHEMBL26478 | 1.00 | TBXA2R (1.00) | TBXA2RADRA1ASLC6A3ADORA3ABCB11 | |
| SCHEMBL13097922 | 1.00 | TBXA2R (1.00) | TBXA2RADRA1ASLC6A3ADORA3ABCB11 | |
| Amlodipine SCHEMBL29664887 | 1.00 | TBXA2R (1.00) | TBXA2RADRA1ASLC6A3ADORA3ABCB11 | |
| SCHEMBL29599419 | 1.00 | TBXA2R (1.00) | TBXA2RADRA1ASLC6A3ADORA3ABCB11 | |
| Amlodipine SCHEMBL6666635 | 0.99 | TBXA2R (0.98) | TBXA2RADRA1ASLC6A3ADORA3ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 19048 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075488-A | Compound preparation for treating hypertension and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122072268-A | Method for optimizing dissolution curve of tablet and in-vivo bioequivalence | 北京阳光诺和药物研究股份有限公司 | 2026-05-22 | — | — | CN | claimed |
| US-20260130866-A1 | IMMEDIATE RELEASE AMLODIPINE UBIQUINONE COMPOSITION FOR ENHANCED IMMUNOMODULATORY ACTIVITY | KHAN ABIDA (SA) | 2026-05-14 | — | — | US | claimed |
| CN-121015662-B | Olmesartan medoxomil amlodipine hydrochlorothiazide three-compound preparation and preparation method and application thereof | 上海腾瑞制药股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260124187-A1 | COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION | THE GEORGE INST FOR GLOBAL HEALTH (AU) | 2026-05-07 | — | — | US | claimed |
| EP-4710920-A1 | PHARMACEUTICAL COMPOSITION COMPRISING COMBINATION OF AMLODIPINE, RAMIPRIL AND ROSUVASTATIN | Adamed Pharma S.A. (PL) | 2026-03-18 | — | — | EP | claimed |
| US-20260060968-A1 | COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION | The George Institute for Global Health (AU) | 2026-03-05 | — | — | US | claimed |
| EP-4694856-A1 | CALENDAR MEDICATION BLISTER PACK, METHOD OF USING THEREOF AND ELECTRONIC SYSTEM OF MANAGEMENT OF INTERACTION WITH CALENDAR MEDICATION BLISTER PACK | Mili Healthcare Trade Fzco (AE) | 2026-02-18 | — | — | EP | claimed |
| EP-4691556-A2 | HUMANIZED ANTI-ACTH ANTIBODIES AND USE THEREOF | H. Lundbeck A/S (DK) | 2026-02-11 | — | — | EP | claimed |
| US-12544341-B2 | Methods of preparing multiphase statin and omega-3 fatty acid soft capsule formulations | CATALENT ONTARIO LIMITED (CA) | 2026-02-10 | — | — | US | claimed |
| WO-1999018957-A1 | STABLE PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPINE BESYLATE AND ATENOLOL | REDDY-CHEMINOR, INC. (US) | 1999-04-22 | — | — | WO | claimed |
| WO-1999011263-A1 | COMBINATION THERAPY COMPRISING AMLODIPINE AND A STATIN COMPOUND | PFIZER PRODUCTS INC. (US) | 1999-03-11 | — | — | WO | claimed |
| WO-1999011259-A1 | THERAPEUTIC COMBINATIONS COMPRISING AMLODIPIN AND ATORVASTATIN | PFIZER INC. (US) | 1999-03-11 | — | — | WO | claimed |
| EP-0751938-B1 | SEPARATION OF THE ENANTIOMERS OF AMLODIPINE VIA THEIR DIASTEREOMERIC TARTRATES | PFIZER LTD (GB) | 1998-05-13 | — | — | EP | claimed |
| EP-0661970-A1 | METHODS AND COMPOSITIONS FOR TREATING HYPERTENSION, ANGINA AND OTHER DISORDERS USING OPTICALLY PURE (-) AMLODIPINE | SEPRACOR, INC. (US) | 1995-07-12 | — | — | EP | claimed |
| EP-0661970-A4 | METHODS AND COMPOSITIONS FOR TREATING HYPERTENSION, ANGINA AND OTHER DISORDERS USING OPTICALLY PURE (-) AMLODIPINE. | SEPRACOR INC (US) | 1994-12-16 | — | — | EP | claimed |
| EP-0566142-A1 | Inclusion complexes of optically active and racemic 1,4-dihydro pyridines with cyclodextrin derivates | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. (SI) | 1993-10-20 | — | — | EP | claimed |
| EP-0551626-A1 | Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. (SI) | 1993-07-21 | — | — | EP | claimed |
| WO-1993010779-A1 | METHODS AND COMPOSITIONS FOR TREATING HYPERTENSION, ANGINA AND OTHER DISORDERS USING OPTICALLY PURE (-) AMLODIPINE | SEPRACOR, INC. (US) | 1993-06-10 | — | — | WO | claimed |
| EP-0459666-A2 | Medicaments against impotence | PFIZER INC. (US) | 1991-12-04 | — | — | EP | claimed |